SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019266
Filing Date
2017-11-14
Accepted
2017-11-14 11:43:47
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc20170930_10q.htm 10-Q 609094
2 EXHIBIT 31.1 ex_100143.htm EX-31.1 13252
3 EXHIBIT 31.2 ex_100144.htm EX-31.2 12953
4 EXHIBIT 32.1 ex_100145.htm EX-32.1 6690
5 EXHIBIT 32.2 ex_100146.htm EX-32.2 6887
  Complete submission text file 0001437749-17-019266.txt   4700606

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tlcc-20170930.xml EX-101.INS 993647
7 XBRL TAXONOMY EXTENSION SCHEMA tlcc-20170930.xsd EX-101.SCH 54446
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlcc-20170930_cal.xml EX-101.CAL 38927
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlcc-20170930_def.xml EX-101.DEF 356545
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlcc-20170930_lab.xml EX-101.LAB 301626
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlcc-20170930_pre.xml EX-101.PRE 375362
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 171199483
SIC: 2833 Medicinal Chemicals & Botanical Products